4 Patents
- US118458022023Combination Therapy with a Glucagon Receptor (GCGR) Antibody and an Anti-cd3 Antibody
NGM Biopharmaceuticals, Inc.
0 cites - 0 cites
- US117320492023Methods of Reducing or Lowering Blood Glucose Levels in a Human Subject by Administering an Antibody That Specifically Binds Human Glucagon Receptor
NGM Biopharmaceuticals, Inc.
0 cites - US115660672023Methods of Lowering Triglyceride Levels with an Angptl8-binding Antibody or Antigen-binding Fragment Thereof
NGM Biopharmaceuticals, Inc.
0 cites